Roivant Sciences Ltd. (ROIV)

Nasdaq · Healthcare · Biotechnology
$38.66-0.78%As of 2026-11-22 · USD
Last session low $38.46Last session high $39.51
52-week low $19.9652-week high $42.50
Market cap
$28.01B
Sector
Healthcare
Next earnings
2027-02-04 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)55.5In the neutral range (30 to 70)
MACD (12, 26, 9)0.77Below its signal line (0.83); histogram -0.05
Bollinger %B (20, 2)54%Inside the bands (34.93 to 41.79)
SMA 2038.36Price is 0.8% above
SMA 5037.19Price is 3.9% above
SMA 20032.74Price is 18.1% above
ATR (20)3.73% of priceAverage true range per day
52-week position83%In the upper part of the 19.96 to 42.50 range

About Roivant Sciences Ltd.

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies.

Insider filings, 90 daysNo purchases and 12 sales (about $58.0M).
Latest fiscal yearEnded 2026-03-31: revenue of $8.26M and an operating margin of -15560.6%.
Next earnings reportExpected on 2027-02-04 (the date is an estimate).

More in Biotechnology